Diligence memo · auto-generated · as of July 2, 2026
NOLA PharmaHoldings, LLC
NOLA PharmaHoldings, LLC looks fair against its niche peers and is quiet on financing cadence.
Businessfiled
NOLA PharmaHoldings, LLC operates in Biotech / Pharma, based in LITTLE ROCK.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
NOLA PharmaHoldings, LLC has raised $48M in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Series C (a $40M–$100M round).
Largest single filing: $48M on 2024-05-10.
Most recent recorded round closed around 2024-05-10.
Valuation (modeled)modeled
Provath models NOLA PharmaHoldings, LLC at approximately $448M (range $153M–$694M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Fair. Modeled value is 0.89× the median modeled value of Series C Biotech / Pharma companies in 2022–2024 (8 peers) — value vs value, same stage and era. Within the normal band (89% of peer median) for its niche.
Financing rhythm & timingmixed
Last raise 2.1 yr ago; this sector typically re-raises about every 15 months.
Slightly overdue versus sector cadence.
Comparablesmixed
Capital scale ranks ahead of 89% of Biotech / Pharma peers (227 compared).
Modeled value ranks above 89% of those peers.
Closest niche peers: Sherlock Biosciences, Inc., Pacific Biosciences Of California, Inc., Sudo Biosciences, Inc., Elephas Biosciences Corp, Belenos Biosciences, Inc..
Peoplefiled
6 named people on file across officers, directors and signatories.
Risks & flagsmixed
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.